Frontlight ResearchEarly access
Trial site
Centrum Alergologii Sp. z o.o.
- 3running trials
- 3closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Asthma2 trials
- Chronic spontaneous urticaria2 trials
- Atopic dermatitis (eczema)1 trial
- COPD1 trial
- Phase
- Phase 36 trials
- Status
- Active, not recruiting2 trials
- Completed2 trials
- Not yet recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- AstraZeneca1 trial
- Celldex Therapeutics1 trial
- Curateq Biologics Private Limited1 trial
- Hoffmann-La Roche1 trial
- Inmunotek S.L.1 trial
- and 1 more
Running trials
Not yet recruiting
Clinical trial to assess the efficacy and safety of a vaccine for grass pollen allergy.
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma1 recruiting
Closed trials
Recruiting
Completed
BP11 Versus EU-Approved Xolair® in Patients With Chronic Spontaneous Urticaria
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 15 Nov 2026